> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Percutaneous Nerve Stimulator for Substance Disorder in Class 2
- URL: https://www.fdaweb.com/percutaneous-nerve-stimulator-for-substance-disorder-in-class-2/
- Published: 2018-02-05T12:00:00.000Z
- Updated: 2026-09-14T23:19:52.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140676

*Federal Register* notice: FDA has classified the percutaneous nerve stimulator for substance use disorders into Class 2 (special controls). The action is in response to a 3/2017 de novo request from Innovative Health Solutions for its NSS–2 Bridge device. It has identified the product as a device that stimulates nerves percutaneously to aid in reducing withdrawal symptoms associated with substance use disorders. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-02-05/pdf/2018-02202.pdf?ref=fdaweb.com).